Recently, Zebra Medical Vision, a deep learning medical image analysis platform, completed a $30 million Series C round of financing. The leading investor in this round of financing is aMoon Ventures, including KK Benioff, founder of Khosla Ventures, NVIDIA, Salesforce, Richard Socher, chief scientist of Salesforce, Li Feifei, chief scientist of Google Cloud, OurCrowd, Dolby Ventures, Aurum, Johnson & Johnson Innovation JJDC and Intermountain Healthcare.
Founded in Israel in 2014, Zebra uses millions of scanned images to collect data and train its deep learning engine to help radiologists automatically detect medical problems, including bone, liver, lung and cardiovascular systems. disease. Maybe medical experts can diagnose certain diseases in the picture at a glance, but Zebra's automatic picture analysis can find some diseases that are not easy to find.
Zebra has previously completed $20 million in financing. It will use this new financing to allow its analysis to cover the rest of the body. In addition to the financing announcement, the company also announced a new chest x-ray analysis product, which indicates that the product has been trained in 2 million pictures to help diagnose 40 diseases.
When it comes to cost, Zebra announced in October last year that it changed its fee structure. In the past, it charged for scans, and now it charges $1 per check. This is to "conform to the company's founder's vision of global expansion, transparency and price reduction." The company has confirmed that the company will continue to use this model in every market in the future.
Zebra is currently licensed to operate in Europe, Australia, New Zealand, Brazil and other Latin American and Asian markets. A spokesperson said that Zebra expects to be “quickly†certified by the US Food and Drug Administration.
Anesthesia Medical Co., Ltd. , https://www.jssinoanesthesia.com